BCTX

Briacell Therapeutics
BCTX

Overview Fund Activity

19 hedge funds and large institutions have $6.38M invested in Briacell Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
2
Increased
7
Reduced
6
Closed
5
Calls
$912K
Puts
$224K
Net Calls
+$688K
Net Calls Change
-$3.67M

Top Buyers

1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$311K
2
SM
Sabby Management
Florida
+$97.9K
3
LCM
Lynwood Capital Management
Ontario, Canada
+$48.9K
4
OBWG
Onyx Bridge Wealth Group
New York
+$43.3K
5
KJHP
K.J. Harrison & Partners
Ontario, Canada
+$18K

Top Sellers

1
WA
Wasatch Advisors
Utah
-$1.56M
2
Morgan Stanley
Morgan Stanley
New York
-$302K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$144K
4
N
Natixis
France
-$130K
5
Simplex Trading
Simplex Trading
Illinois
-$73K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
– -$88 – –
1
2